Anne McGeorge - Sep 11, 2023 Form 4 Insider Report for Dianthus Therapeutics, Inc. /DE/ (MGTA)

Role
Director
Signature
/s/ Adam Veness, as attorney-in-fact for Anne McGeorge
Stock symbol
MGTA
Transactions as of
Sep 11, 2023
Transactions value $
$0
Form type
4
Date filed
9/13/2023, 09:14 PM
Previous filing
Mar 21, 2023
Next filing
Dec 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +6.5K $0.00 6.5K Sep 11, 2023 Common Stock 6.5K $11.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Exhibit 24 - Power of Attorney